# AMY2B

## Overview
The AMY2B gene encodes the enzyme amylase alpha 2B, a member of the glycoside hydrolase family, which is primarily involved in the digestion of dietary starches. This enzyme is predominantly expressed in the pancreas and small intestine, where it facilitates the breakdown of complex carbohydrates into simpler sugars, such as maltose, by hydrolyzing alpha-1,4-glycosidic bonds. Amylase alpha 2B plays a critical role in carbohydrate metabolism and energy production, contributing to the maintenance of blood glucose homeostasis. The enzyme's activity is essential for the functional maturation of intestinal epithelial cells, supporting nutrient absorption and cellular metabolism. Variations in the AMY2B gene have been linked to metabolic conditions, including type 2 diabetes, highlighting its clinical significance in glucose regulation and potential as a therapeutic target (Elder2018Human; Abdulkareem2024Genetic; Date2019α‐Amylase).

## Structure
The AMY2B gene encodes the enzyme amylase alpha 2B, which plays a crucial role in the breakdown of starch into sugars. The primary structure of this enzyme is composed of a specific sequence of amino acids that determine its function and stability. In terms of secondary structure, AMY2B includes both alpha-helices and beta-sheets, which contribute to its overall stability and functionality.

The tertiary structure of amylase alpha 2B is characterized by a globular shape, which is typical for enzymes that need to be soluble and active in the aqueous environment of the cell. This globular form allows the enzyme to efficiently interact with its substrates. The quaternary structure of AMY2B may involve dimerization, which can affect its enzymatic activity and stability.

AMY2B contains a catalytic domain that is typical of glycoside hydrolases, which are enzymes that catalyze the hydrolysis of glycosidic bonds in carbohydrates. This domain is essential for the enzyme's ability to break down starch into simpler sugars. Common post-translational modifications of AMY2B include glycosylation, which can influence the enzyme's stability, activity, and cellular localization. These structural features are critical for the enzyme's function in carbohydrate metabolism.

## Function
The AMY2B gene encodes the enzyme amylase alpha 2B, which plays a crucial role in the digestion of dietary starches by breaking them down into smaller sugars such as maltose. This enzyme is primarily active in the pancreas and small intestine, where it catalyzes the hydrolysis of alpha-1,4-glycosidic bonds in polysaccharides, facilitating carbohydrate digestion and energy production (Elder2018Human; Date2019α‐Amylase).

In the small intestine, AMY2B is expressed in epithelial cells, where it is essential for cell proliferation and differentiation. The enzyme supports the maintenance of a healthy intestinal lumen by promoting rapid cell turnover, which is vital for nutrient absorption and cellular metabolism (Date2019α‐Amylase). AMY2B also binds to N-linked oligosaccharides on glycoproteins, regulating activities related to blood glucose levels and contributing to blood glucose homeostasis (Date2019α‐Amylase).

The expression of AMY2B is differentiation-dependent, with increased mRNA and protein levels as intestinal cells mature. This expression pattern underscores its role in the functional maturation of intestinal epithelial cells (Date2019α‐Amylase).

## Clinical Significance
Mutations and alterations in the expression of the AMY2B gene have been associated with several metabolic conditions, particularly type 2 diabetes (T2D). Variations in the AMY2B gene can lead to differences in amylase production and activity, impacting carbohydrate metabolism. In individuals with T2D, amylase mRNA levels in the pancreas are reduced, but these levels can be restored with insulin treatment, indicating a dependence on insulin for normal amylase expression (Abdulkareem2024Genetic). 

The AMY2B gene is also implicated in the regulation of postprandial blood sugar levels, making it a potential target for managing T2D. Genetic factors, including copy number variations (CNVs) in amylase genes, contribute to T2D susceptibility, although the disease is not directly caused by mutations in pancreatic amylase genes. Instead, T2D results from interactions between multiple genes and environmental factors (Abdulkareem2024Genetic).

Additionally, structural variations and CNVs involving AMY2B have been observed, with higher-order expansions such as triplication and quadruplication being identified. These variations are more prevalent in certain populations and may have been selectively advantageous in human history, potentially influencing dietary adaptation (Shwan2017Recurrent).


## References


[1. (Elder2018Human) Patrick J.D. Elder, David B. Ramsden, David Burnett, Martin O. Weickert, and Thomas M. Barber. Human amylase gene copy number variation as a determinant of metabolic state. Expert Review of Endocrinology &amp; Metabolism, 13(4):193–205, July 2018. URL: http://dx.doi.org/10.1080/17446651.2018.1499466, doi:10.1080/17446651.2018.1499466. This article has 26 citations.](https://doi.org/10.1080/17446651.2018.1499466)

[2. (Shwan2017Recurrent) Nzar A.A. Shwan, Sandra Louzada, Fengtang Yang, and John A.L. Armour. Recurrent rearrangements of human amylase genes create multiple independent cnv series: human mutation. Human Mutation, 38(5):532–539, February 2017. URL: http://dx.doi.org/10.1002/humu.23182, doi:10.1002/humu.23182. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23182)

[3. (Abdulkareem2024Genetic) Mutiat A. Abdulkareem, Bunmi A. Owolabi, Emmanuel S. Saheed, Remilekun F. Aromolaran, Rukayat M. Bashiru, Toheeb A. Jumah, Doris U. Chijioke, Onyinyechi J. Amaechi, Fehintoluwa C. Adeleke, Omiyale O. Charles, and Tunde S. Oluokun. Genetic factors and the role of pancreatic amylase in the pathogenesis of type 2 diabetes. Egyptian Journal of Medical Human Genetics, March 2024. URL: http://dx.doi.org/10.1186/s43042-024-00505-6, doi:10.1186/s43042-024-00505-6. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s43042-024-00505-6)

[4. (Date2019α‐Amylase) Kimie Date, Tomomi Yamazaki, Yoko Toyoda, Kumi Hoshi, and Haruko Ogawa. Α‐amylase expressed in human small intestinal epithelial cells is essential for cell proliferation and differentiation. Journal of Cellular Biochemistry, 121(2):1238–1249, September 2019. URL: http://dx.doi.org/10.1002/jcb.29357, doi:10.1002/jcb.29357. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.29357)